Skip to content
10-Q

Quarterly Report

PARDES BIOSCIENCES, INC.

0000950170-22-017368

← back to feed
Filed
Aug 15, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Aug 10, 2022 62.32M sh
Cash And Equivalents Q2 2022 · Jun 30, 2022 $228.6M
Cash And Equivalents Q2 2022 · Dec 31, 2021 $268.68M
Current Liabilities Q2 2022 · Jun 30, 2022 $11.22M
Current Liabilities Q2 2022 · Dec 31, 2021 $8.97M
Total Liabilities Q2 2022 · Jun 30, 2022 $11.22M
Total Liabilities Q2 2022 · Dec 31, 2021 $8.97M
Current Assets Q2 2022 · Jun 30, 2022 $233.85M
Current Assets Q2 2022 · Dec 31, 2021 $275.26M
Total Assets Q2 2022 · Jun 30, 2022 $233.85M
Total Assets Q2 2022 · Dec 31, 2021 $275.26M
Shares Diluted Q2 2022 · Jun 30, 2021 2.36M sh
Shares Diluted Q2 2022 · Jun 30, 2021 1.55M sh
Operating Cash Flow restated Q2 2022 · Jun 30, 2021 −$9.54M
Stockholders Equity restated Q2 2022 · Jun 30, 2021 −$25.36M
Stockholders Equity restated Q2 2022 · Mar 31, 2021 −$17.45M
Stockholders Equity restated Q2 2022 · Dec 31, 2020 −$13.01M
Eps Diluted Q2 2022 · Jun 30, 2021 −$3.45
Eps Diluted Q2 2022 · Jun 30, 2021 −$8.17
Eps Basic Q2 2022 · Jun 30, 2021 −$3.45
Eps Basic Q2 2022 · Jun 30, 2021 −$8.17
Rd Expense Q2 2022 · Jun 30, 2021 $6.27M
Rd Expense Q2 2022 · Jun 30, 2021 $9.71M
Net Income restated Q2 2022 · Jun 30, 2021 −$8.14M
Net Income restated Q2 2022 · Jun 30, 2021 −$12.66M
Net Income Q2 2022 · Mar 31, 2021 −$4.52M